Is TG Therapeutics, Inc. overvalued?

TG Therapeutics, Inc. (TGTX) — key valuation metrics and fundamentals.

No verdict

Price

$55.51

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$8.60B

Dividend yield

—

Return on equity

—

Sector

Healthcare

Fair value compares TGTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 29 Jun 2026.

Related stocks